
- Pharmaceutical Technology, November 2024
- Volume 48
- Issue 11
- Pages: 8
Single-use ADC Reactor
The Mobius ADC Reactor is the first single-use reactor designed specifically for the manufacture of antibody drug conjugates.
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, introduced the Mobius ADC Reactor, a single-use reactor designed specifically for the manufacture of antibody drug conjugates (ADCs). The reactor is the first of its kind for ADC production, according to the company. The Mobius ADC Reactor is designed to meet the unique requirements for linking the necessary components for ADCs and aims to enable these critical therapies to be produced faster and more safely with faster turnaround times and fewer cross-contamination risks. Performance improvements using the single-use reactor include elimination of potent liquid waste and a 70% increase in efficiency. The reactor’s single-use assemblies are made of Ultimus Film technology, which provides enhanced bag strength, improved durability, and leak resistance.
Articles in this issue
about 1 year ago
Increasing Processing Flexibility to Meet Demandabout 1 year ago
Automate Aseptic Filling: Closing the System at Full Modularityabout 1 year ago
Strategies for Overcoming Common Challenges in Tech Transferabout 1 year ago
Weathering the Stormsabout 1 year ago
The Importance of Appropriate Supplier Oversightabout 1 year ago
Fixed Tank Dual Shaft Mixer/Pressure Reactorabout 1 year ago
Aseptic Micro-ConnectorNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





